Nicoya Lifesciences

What Nicoya Lifesciences does

Nicoya Lifesciences is a privately held Canadian life sciences instrumentation company founded in 2012 and headquartered in Kitchener, Ontario, that designs, manufactures, and sells label-free biophysical characterization platforms used by pharmaceutical companies, contract research organizations, and academic researchers studying protein interactions, structure, stability, and dynamics. Its core technology portfolio spans surface plasmon resonance (SPR) systems built on localized surface plasmon resonance and digital microfluidics (OpenSPR, Alto, and Revo), a millisecond-resolution hydrogen-deuterium exchange mass spectrometry platform (FastHDX), the world's most-cited stopped-flow kinetics system (SX20), a circular dichroism spectrometer (Chirascan), and a plate-based differential scanning fluorimetry instrument (SUPR-DSF), all supported by the Nicosystem acquisition and analysis software. The portfolio was materially expanded by the June 2025 acquisition of Applied Photophysics, which added the Chirascan, SX20, and FastHDX product lines and established a European hub in Leatherhead, UK; a 2022 acquisition of LSK Technologies added a digital microfluidic lab-in-a-box diagnostic platform.

Nicoya sells its instruments primarily through quote-based direct sales and a global distributor network covering 40+ countries across the Americas, EMEA, and APAC, with exclusive partners in China (TrioBio), India (Medispec), and Southeast Asia (DKSH), complemented by an e-commerce storefront for consumables and sensors. Revenue streams include hardware sales, recurring consumables and cartridge revenue, service and support contracts, and a software/Nicosystem SaaS layer; in October 2024 Nicoya launched what it describes as the world's first SPR instrument subscription plan to reach early-stage biotech startups. Customers include Pfizer, Novartis, Novo Nordisk, Roche, Eli Lilly, AbbVie, and Dana-Farber on the enterprise side, alongside leading academic institutions and over 1,000 labs using the SX20 alone. Total disclosed funding stands at approximately C$35 million, including a C$20 million extended Series A in December 2021 led by Whitecap Venture Partners, with additional backing from BDC, Garage Capital, MaRS IAF, Agilent Technologies, and EDC.

Name

Nicoya Lifesciences

Legal name

Nicoya Lifesciences Inc.

Website

https://nicoyalife.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Nicoya Lifesciences is a privately held Canadian life sciences instrumentation company that designs label-free biophysical characterization platforms (digital SPR, HDX-MS, CD, DSF, stopped-flow) used by pharma, biotech, CROs, and academic labs in 40+ countries.

Ownership category

akta.pro rank

Product category

Biophysical Characterization Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)

akta.pro secondary industry

Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)

Keywords

• Surface plasmon resonance instruments
• Biophysical characterization systems
• Label-free binding kinetics
• Protein dynamics analysis
• Digital microfluidics biosensors

Headquarters

HQ city

Waterloo

HQ country

Canada

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Instrument Sales: Nicoya sells biophysical characterization instruments (Alto, Revo, OpenSPR, SX20, Chirascan, SUPR-DSF, FastHDX) as capital equipment purchases. Payment terms for instrument purchases are 30 days after receipt of goods. Instruments are warranted for 12 months from shipment.
2. Consumables and Sensors: Sale of disposable cartridges, sensor chips, and reagents required for instrument operation. Consumable goods carry a warranty for the stated recommended shelf life. Non-instrument purchases require 100% payment upon PO issuance before shipment.
3. Service and Support Plans: Extended warranty plans (12-month increments after the 12-month standard warranty) and professional services including installation, training, and servicing. Available for OpenSPR, OpenSPR-XT, and Alto instruments.
4. Nicosystem SaaS: Nicosystem software as a service offering governed by a separate SaaS agreement. Mentioned in the Terms of Sale as a distinct revenue stream requiring separate terms.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Nicoya Lifesciences develops and manufactures an integrated portfolio of label-free biophysical characterization instruments and consumables for protein interaction, structure, stability, and dynamics research. The core line includes digital SPR systems (Alto, Revo, OpenSPR) using proprietary digital microfluidics and LSPR nanosensors, complemented by millisecond HDX-MS (FastHDX), stopped-flow kinetics (SX20), circular dichroism (Chirascan), and differential scanning fluorimetry (SUPR-DSF), sold with proprietary cartridges, sensors, Nicosystem software, and service plans to pharmaceutical, biotech, academic, and CRO laboratories.

Product overview

Nicoya Lifesciences offers an integrated portfolio of label-free biophysical characterization instruments for biologics discovery and development. The product portfolio includes three digital SPR platforms: Alto (16-channel high-throughput), Revo (4/8-channel benchtop), and OpenSPR (2-channel entry-level LSPR). Structural dynamics are addressed through FastHDX (millisecond HDX-MS) and SX20 (stopped-flow kinetics). Stability and structure are characterized via SUPR-DSF (intrinsic DSF) and Chirascan (circular dichroism). Supporting software includes Nicosystem (data acquisition/analysis), Alto GxP Suite (regulatory compliance), and Alto Automation Suite (24/7 operation). The portfolio was significantly expanded through the acquisition of Applied Photophysics in June 2025, which added the Chirascan CD, SX stopped-flow, and FastHDX platforms to Nicoya's offerings. Founded in 2012 and headquartered in Kitchener, Ontario, the company serves scientists in over 40 countries.

Differentiator

Problem solved

Functional benefit

Brands

• OpenSPR: Entry-level benchtop SPR instrument using localized surface plasmon resonance (LSPR) technology for label-free binding kinetics and affinity measurements
• Alto
• Revo
• SUPR-DSF
• Chirascan
• SX20
• FastHDX
• Nicosystem

Products and services

• Alto Digital SPR System High-throughput digital SPR system and the world's first cartridge-based SPR platform, delivering 16 parallel channels with up to 240 binding curves per experiment using only 2 µL of sample. Integrates digital microfluidics with nanosensors for automated kinetics, affinity, epitope binning, and quantitation assays for pharma, biotech, academic, and CRO customers.
• Revo Digital SPR System 4- or 8-channel digital SPR benchtop system combining digital microfluidics with nanotechnology-based LSPR biosensors. Offers maintenance-free disposable cartridges, ultra-low 2 µL sample consumption, and supports up to 36 interactions per cartridge with crude sample compatibility, designed for accessible, real-world biologics research.
• OpenSPR LSPR Instrument 2-channel benchtop Localized Surface Plasmon Resonance (LSPR) instrument providing entry-level, cost-effective label-free SPR measurements. Uses proprietary nanosensor technology with simplified optical hardware for affordable, robust binding kinetics and affinity analysis, used by over 600 researchers worldwide for publication-quality data.
• FastHDX Millisecond HDX-MS Platform Hydrogen-deuterium exchange mass spectrometry (HDX-MS) platform capable of millisecond (1 ms) labeling resolution, enabling capture of transient protein conformational states in intrinsically disordered proteins and disease-relevant systems. Features broad labeling time range (50 ms to 24+ hours), 8 µL sample consumption per time point, and seamless integration with standard LC-MS workflows; developed by the Applied Photophysics team acquired in June 2025.
• SX20 Stopped-Flow System World's most-cited stopped-flow system for ultra-fast kinetics measurements. Captures millisecond reactions with dual-detection capabilities (fluorescence, absorbance, FRET), high-speed spectral acquisition, and pneumatic mixing. Trusted by over 1,000 labs worldwide with 12,000+ peer-reviewed publications.
• SUPR-DSF Differential Scanning Fluorimetry Reader Plate-based intrinsic differential scanning fluorimetry (DSF) microplate reader for protein thermal stability screening. Measures melting temperature (Tm) and non-reversibility onset (Tnr) without dyes or proprietary consumables. Supports up to 384 samples per experiment with 10 µL sample volumes.
• Chirascan Circular Dichroism Spectrometer High-sensitivity circular dichroism (CD) spectroscopy platform for protein structural and conformational analysis. Available in three variants: VX (routine analysis), V100 (enhanced sensitivity for low-concentration samples), and Q100 (automated for regulated QA/QC environments). Detects secondary, tertiary, and higher-order structural changes.
• Nicosystem Software Platform Comprehensive software platform for the Alto and Revo instruments providing centralized acquisition and analysis of real-time binding data with intuitive interface, one-click assay analysis, and cloud-based experiment access and sharing. Includes Alto GxP Suite (21 CFR Part 11 compliance) and Alto Automation Suite for 24/7 unattended SPR analysis. Offered as a separate SaaS subscription.
• Service and Support Plans Extended warranty plans (12-month increments beyond the 12-month standard warranty) and professional services including installation, training, and servicing for OpenSPR, OpenSPR-XT, and Alto instruments.
• SPR Instrument Subscription Plan World's first SPR instrument subscription plan offering monthly access to SPR instruments, designed to lower upfront capital requirements and make SPR technology accessible to early-stage biotech startups.

Quantifiable outcome

• 4-5 order-of-magnitude improvement in HDX labeling resolution over conventional techniques with FastHDX
• +5 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered major and core.

• Canada-UK BALANCE ProjectmajorStrategic or Co-development Partner · 24 July 2025A Canada-UK collaboration developing AI-powered bioreactors to revolutionize biopharmaceutical manufacturing. The project involves using Nicoya Alto for quantitation and bioreactor characterization, representing a strategic cross-border academic-industry partnership.
• Broad Institute of MIT and HarvardmajorStrategic or Co-development Partner · 13 June 2025Nicoya and researchers from the Broad Institute collaborate to advance the future of HDX-MS technology, leveraging FastHDX for novel applications in structural biology and drug discovery.
• TrioBio Biotech, Ltd. (Triobio)coreChannel Partner/ Reseller/ Distributor · 16 April 2024TrioBio serves as the exclusive distributor for Nicoya products in China, Hong Kong, and Macau. This partnership strengthens Nicoya's presence in the China market.
• MedispeccoreChannel Partner/ Reseller/ Distributor · 13 February 2024Medispec was appointed as the exclusive distributor for Nicoya products in India, marking Nicoya's expansion into the Indian market.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Malvern Panalytical: Malvern Panalytical provides analytical instruments for protein characterization, stability, and biophysics, including DSF and CD-adjacent platforms. It is a broad incumbent overlapping with Nicoya's SUPR-DSF and Chirascan offerings.
• Bruker Corporation: Bruker is a major analytical instrument manufacturer with strong positions in mass spectrometry, HDX-MS, and biophysics. Its timsTOF and HDX-MS systems are competitive with Nicoya's FastHDX and SX20, and it serves overlapping pharma and academic customers.
• Thermo Fisher Scientific: Thermo Fisher offers a broad portfolio of analytical instruments, mass spectrometers, and biophysics tools used across pharma, biotech, and academia. It is a broad incumbent across multiple Nicoya product categories, particularly HDX-MS and CD spectroscopy.
• Molecular Devices (Danaher): Molecular Devices supplies microplate readers, DSF platforms, and biophysical screening instruments used in drug discovery. It competes with Nicoya's SUPR-DSF and is a broad incumbent in protein stability screening for pharma and academic labs.
• Agilent Technologies: Agilent is a leading analytical instrument and LC-MS company that is both a Nicoya technology integration partner (1290 Infinity II bio LC and 6545XT Q-TOF referenced in Nicoya application notes) and a broader competitor in mass spectrometry-based protein characterization.
• Waters Corporation: Waters is a leading mass spectrometry and LC company with HDX-MS solutions used in protein structural biology. It is a natural broad incumbent to FastHDX, with overlap in pharma and academic accounts that Nicoya's HDX-MS platform is targeting.

Direct peers

• Cytiva (Biacore): Cytiva's Biacore line is the dominant SPR instrument franchise serving pharma and academic biophysics labs worldwide. It is the most direct competitor to Nicoya's Alto, Revo, and OpenSPR platforms in label-free binding kinetics and affinity analysis.
• HORIBA Scientific: HORIBA Scientific is a leading supplier of spectroscopy and CD instruments used for protein structural analysis. It is a direct peer to Nicoya's Chirascan in CD spectroscopy for biophysics labs.
• JASCO (Japan Spectroscopic Company): JASCO is a major manufacturer of circular dichroism and spectroscopy instruments serving academic and pharmaceutical biophysics labs. It directly competes with Nicoya's Chirascan CD platform in structural biology and protein characterization.
• Sartorius (FortéBio / Octet): Sartorius's FortéBio Octet is a leading bio-layer interferometry (BLI) platform for label-free binding kinetics used alongside SPR. It competes with Nicoya's digital SPR instruments in biologics discovery, lead optimization, and process development workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nicoya_life
• Facebookfacebook.com/NicoyaLife
• LinkedInlinkedin.com/company/nicoya-lifesciences
• Instagraminstagram.com/nicoya_life

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds8 records

Investors23 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nicoya Lifesciences